Invictus MD Strategies Financials

GENEDelisted Stock  USD 0.77  0.00  0.00%   
We strongly advise to harness Invictus analysis to find out if markets are presently mispricing the company. We were able to interpolate thirty-five available reported financial drivers for Invictus MD Strategies, which can be compared to its competitors. The stock experiences a normal downward trend, but the immediate impact on correlations cannot be determined at the moment . Check odds of Invictus to be traded at $0.7623 in 90 days.
  
Understanding current and past Invictus Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Invictus' financial statements are interrelated, with each one affecting the others. For example, an increase in Invictus' assets may result in an increase in income on the income statement.
Please note, the presentation of Invictus' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Invictus' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Invictus' management manipulating its earnings.

Invictus Stock Summary

Invictus competes with T2 Biosystms, Intelligent Bio, BioAffinity Technologies,, Agilent Technologies, and Sera Prognostics. Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage peoples health in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia. Genetic Tech operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 52 people.
InstrumentCanada Stock View All
ExchangeTSX Venture Exchange
Business Address321 Chapel Street,
SectorLife Sciences Tools & Services
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitegenetype.com
Phone61 3 8412 7000
CurrencyUSD - US Dollar
You should never invest in Invictus without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Invictus Stock, because this is throwing your money away. Analyzing the key information contained in Invictus' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Invictus Key Financial Ratios

There are many critical financial ratios that Invictus' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Invictus MD Strategies reports annually and quarterly.

Invictus Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Invictus's current stock value. Our valuation model uses many indicators to compare Invictus value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Invictus competition to find correlations between indicators driving Invictus's intrinsic value. More Info.
Invictus MD Strategies is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Invictus' earnings, one of the primary drivers of an investment's value.

Invictus Market Pulse

 Quote0.77
 Change(%) 0.00  
 Change0.00 
 Open0.77
 Low0.77
 High0.77
 Volume0
 ExchangeV
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Consideration for investing in Invictus Stock

If you are still planning to invest in Invictus MD Strategies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Invictus' history and understand the potential risks before investing.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Bonds Directory
Find actively traded corporate debentures issued by US companies
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.